"HLA-DR Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
    
    
        
            
            
                A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS.
    
            
            
                
                    
                        
                            | Descriptor ID | D006684 | 
                        
                            | MeSH Number(s) | D12.776.395.550.509.400.440 D12.776.543.550.440.400.440 D23.050.301.500.400.400.440 D23.050.301.500.450.400.440 D23.050.705.552.410.400.440 D23.050.705.552.450.400.440 | 
                        
                            | Concept/Terms |  | 
                    
                
             
            
                Below are MeSH descriptors whose meaning is more general than "HLA-DR Antigens".
                
             
            
            
                Below are MeSH descriptors whose meaning is more specific than "HLA-DR Antigens".
                
             
         
     
 
                                            
                                                
	
	
		
			
			
					
				This graph shows the total number of publications written about "HLA-DR Antigens" by people in this website by year, and whether "HLA-DR Antigens" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1995 | 1 | 0 | 1 | 
| 1997 | 1 | 0 | 1 | 
| 2002 | 0 | 1 | 1 | 
| 2004 | 1 | 1 | 2 | 
| 2006 | 2 | 0 | 2 | 
| 2007 | 1 | 0 | 1 | 
| 2008 | 0 | 2 | 2 | 
| 2009 | 1 | 1 | 2 | 
| 2010 | 0 | 1 | 1 | 
| 2013 | 1 | 0 | 1 | 
| 2014 | 0 | 1 | 1 | 
| 2016 | 0 | 1 | 1 | 
| 2017 | 6 | 9 | 15 | 
| 2018 | 5 | 10 | 15 | 
| 2019 | 3 | 5 | 8 | 
| 2020 | 2 | 8 | 10 | 
| 2021 | 2 | 4 | 6 | 
                   To return to the timeline, click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "HLA-DR Antigens" by people in Profiles.
						
					
								- 
								Monocytes and Macrophages in COVID-19. Front Immunol. 2021; 12:720109. 
- 
								Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy. Front Immunol. 2021; 12:693269. 
- 
								Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732. 
- 
								Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns. J Intern Med. 2021 09; 290(3):677-692. 
- 
								Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children. Sci Immunol. 2021 05 25; 6(59). 
- 
								Letter to the Editor: CD14+HLA-DR+ Cells in Patients May Be a Biomarker Reflecting the Progression of COVID-19. Viral Immunol. 2021 10; 34(8):579-581. 
- 
								Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science. 2021 06 18; 372(6548):1336-1341. 
- 
								Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection. Cell Rep Med. 2021 06 15; 2(6):100291. 
- 
								Case Report: Interferon-? Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome. Front Immunol. 2021; 12:645124. 
- 
								High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients. Cell Mol Life Sci. 2021 Apr; 78(8):3987-4002.